Introduction
Cyclic AMP (cAMP), one of the major intracellular messengers, stimulates catecholamine biosynthesis. Tyrosine hydroxylase, a rate-limiting enzyme in catecholamine synthesis ( 1) , is activated by phosphorylation with cAMP-dependent protein kinase (protein kinase A) (2) , and expression of this enzyme is enhanced by the protein kinase A pathway (3 ) . Biosynthesis of tetrahydrobiopioterin (BH4), an essential cofactor for tyrosine hydroxylase (I), is also enhanced by cyclic AMP (4) (5) (6) (7) (8) and when the amount of BH4 is increased in this manner within the cell it may engage cooperativity with stimulated tyrosine hydroxylase in catecholamine biosvnthesis.
BH4 has also been reported to have other functions such as stimulation of monoamine neurotransmitter release in the brain (9, 10), cofactor activity for nitric oxide synthase (11, 12 ) and stimulation of erythroleukemia cell proliferation (13, 14) , indicating that BH4 has a wide range of activity, both in the extracellular fluid as well as possibility within those cells which do not produce BH4 themselves. Since BH4 synthesis occurs inside the cell, its transport out of the cell is crucial for its extracellular activity. However, almost no information is as yet available concerning BH4 transport and regulation of the extracellular BH4 level. In a previous study, we found that treatment of pheochromocytoma PC12 cells with dibutyryl cAMP (dBcAMP ) lowered the biopterin level in the medium, although it increased the cellular BH4 content (15 ) , suggesting that cAMP has an inhibitory effect of cAMP on bipopterin transport.
In the present paper, we examined the effects of protein synthesis inhibition on cAMP-dependent modulation of biopterin levels. dBcAMPinduced increases in GTP cyclohydrolase I activity and in the intracellular biopterin content of PC 12 cells were blocked by cycloheximide as well as b\· actinomycin D. The dBcAMP-induced decrease in biopterin in the medium was also blocked by these inhibitirs. Treatment of PC12 cells with either cycloheximide or actinomycin D alone 100\ ·ere,~ the cellular biopterin level without decreasing th e amounts of biopterin and pterin in the medium These results suggest that the extracellular bior'tc · rin level is mainly regulated by inhibition of the biopterin outward flow and that this inhibi t:, ·,· process is mediated by protein(s) whose s\·nth,> , is stimulated by cAMP.
Materials and Methods
PC12 cells were cultured in Dulbe(((l" ""' :'. ",: ified Eagle 's medium supplemented "it h -._ .-' bovine serum, 7% horse serum , 100 u: ,::-e ;--tomycin, and 100 units/ ml penicillin l b «( , were seeded on 5 em-diameter dishes ,)~ : : -.,-< plates and were used for experiments after 2 to 3 days of culture. Biopterin and pterin in PC12 cells and in the medium were measured as described previously (5), essentially according to the method of Fukushima and Nixon (17) . GTP cyclohydrolase I activity was assayed according to a previously described method (6, 8) . dBcAMP, cycloheximide, actinomycin D, and alkaline phosphatase were purchased from Sigma, and frtal bovine serum, horse serum and the antibotics mixture were from GIBCO .
Results and Discussion
As shown in Fig. 1 and Table 1 , in PC12 cells, dBcAMP increased the level of cellular BH4 and the activity of GTP cyclohydrolase I, a rate -limiting enzyme in biopterin biosynthesis ( 19) . The increase in the enzyme activity was dependent on the dBcAMP concentration used for treating the cells. The effects of dBcAMP on the cellular BH4 level (Table 1 ) and the enzyme activity (Fig 1) were completely blocked by a protein synthesis inhibitor, cycloheximide as well as by an RNA synthesis inhibitor, actinomycin D, indicating that induction of GTP cyclohydrolase I is essential for raising the level of cellular BH4 by dBcAMP. dBcAMP also increased the intracellular biopterincontent in PC12 cells in a concentration dependent manner (not shown), however biopterin and pterin (2-amino-4-hydroxypteridine ) con ten ts in the medium were decreased (Table l), indicating that dBcAMP has an inhibitory effect on biopterin transport. dBcAMP loered the pteridine level in the medium in a concentration-dependent manner (not shown) but this effect was blocked by cotreatment of cells with 50 J..!g/ ml cycloheximide (Table l) or with 5 Ilg/ ml actinomycin D (not shown), indicating that protein synthesis was required for the dBcAMP-dependent inhibition of the outward of biopterin .
As we already reported (5), almost all pterin in PCl2 cells is biopterin and is present in the tetrahydro form. Furthermore, BH4 is also the predominant pterin in rat serum in vivo. Therefore, biopterin may be transported to the extracellular fluid in the tetrahydro form. In PC 12 cell culture, the amount of pterin in the extracellualr fluid was 1.6-to 2-fold higher than that of biopterin (Table l) . These results also support the above assumption because a substantial proportion of BH4 is known to be converted to pterin when it is oxidized under alkaline or neutral pH conditions although the dihydro and oxidized forms of biopterin are not ( 16 ) and also because pterin cannot be converted to biopterin in the medium . Finally, it is very interesting that cycloheximide lowered the cellular biopterin level to about 60% of the control, although it failed to lower the pterin level in the medium (Table 1 ) . Furthermore, although cycloheximide as weI as actinomycin D decreased the GTP cyclohydrolase activity to 65-70% of the control value, the total pterin content (cellular biopterin and pterin+medium biopterin and pterin (225± 2.04 and 291 ± 1.98) were calculated as means ± SE of control and cycloheximide-treated cultures, respectively) of the PC 12 culture was not significantly affected. These results together with those showing the effect of these inhibitors on dBcAMP-dependent inhibition of biopterin transport strongly suggest that the extracellular biopterin level is controlled by regulating the outward flow ofBH4 from the eel and that this process is mediated by a protein (s) which somehow inhibits BH4 transport to the extracellular fluid.cAMP may lower the extracellular biopterin level by enhancing expression of such inhibitor protein(s).
